August 27, 1992Open Access
View Full PaperA Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection
Key Points
Key points are not available for this paper at this time.
Abstract
Changing treatment from zidovudine to 500 mg per day of didanosine appears to slow the progression of HIV disease.